Kindstar Globalgene Technology (HKSE:09960) Net Margin % : 8.93% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Kindstar Globalgene Technology's Net Income for the six months ended in Jun. 2023 was HK$48 Mil. Kindstar Globalgene Technology's Revenue for the six months ended in Jun. 2023 was HK$539 Mil. Therefore, Kindstar Globalgene Technology's net margin for the quarter that ended in Jun. 2023 was 8.93%.

The historical rank and industry rank for Kindstar Globalgene Technology's Net Margin % or its related term are showing as below:

HKSE:09960' s Net Margin % Range Over the Past 10 Years
Min: -156.28 Med: -20.39 Max: 5.44
Current: 4.27

HKSE:09960's Net Margin % is ranked better than
63.72% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.145 vs HKSE:09960: 4.27

Kindstar Globalgene Technology Net Margin % Historical Data

The historical data trend for Kindstar Globalgene Technology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Net Margin % Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-20.39

-109.27

-156.28

5.44

4.27

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial					9.60	9.48	1.78	8.93	-0.57

Competitive Comparison of Kindstar Globalgene Technology's Net Margin %

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kindstar Globalgene Technology's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's Net Margin % distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's Net Margin % falls into.

Kindstar Globalgene Technology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Kindstar Globalgene Technology's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin	=	Net Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	84.264	/	1548.427
	=	5.44 %

Kindstar Globalgene Technology's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	48.107	/	538.971
	=	8.93 %

Kindstar Globalgene Technology (HKSE:09960) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Kindstar Globalgene Technology Net Margin % Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines